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Abstract
Background: In an earlier study, we detected an association between human T-cell lymphotropic virus (HTLV) infection and
cervical human papillomavirus (HPV) in indigenous Amazonian Peruvian women of the Shipibo-Konibo ethnic group. As
both HTLV and HPV can be transmitted sexually, we now report a population-based study examining the prevalence and
risk factors for HTLV-1 and HTLV-2 infection in this population.
Methods: Between July and December 2010, we conducted a comprehensive screening for HTLV among Shipibo-Konibo
women 15 to 39 years of age living in two communities located in Lima and in 17 communities located within four hours by
car or boat from the Amazonian city of Pucallpa in Peru.
Results: We screened 1,253 Shipibo-Konibo women for HTLV infection 74 (5.9%) tested positive for HTLV-1, 47 (3.8%) for
HTLV-2 infection, and 4 (0.3%) had indeterminate results. In the multivariate analysis, factors associated with HTLV-1
infection included: older age (Prevalence Ratio (PR): 1.04, 95% CI 1.00–1.08), primary education or less (PR: 2.01, 95% CI:
1.25–3.24), younger or same age most recent sex partner (PR: 1.66, 95% CI: 1.00–2.74), and having a most recent sex partner
who worked at a logging camp (PR: 1.73, 95% CI: 1.09–2.75). The only factor associated with HTLV-2 infection was older age
(PR: 1.08, 95% CI: 1.03–1.12).
Conclusion: HTLV infection is endemic among Shipibo-Konibo women. Two characteristics of the sexual partner (younger
age and labor history) were associated with infection in women. These results suggest the need for implementation of both
HTLV screening during the antenatal healthcare visits of Shipibo-Konibo women, and counseling about the risk of HTLV
transmission through prolonged breastfeeding in infected women. We also recommend the implementation of prevention
programs to reduce sexual transmission of these viruses.
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Background
Human T-cell lymphotropic virus type 1 (HTLV-1) was the first
oncogenic human retrovirus to be discovered [1]. Currently, there
are three other known members of the HTLV family of viruses:
HTLV-2, HTLV-3 and HTLV-4 [2–4]. HTLV-1 is associated
with adult T-cell leukemia/lymphoma and with myelopathy/
tropical spastic paraparesis [5–7]. HTLV-1 is also associated with
tuberculosis, uveitis, infective dermatitis, and strongyloidiasis [8–
11]. HTLV-2 infection produces less disease than HTLV-1, but
has been associated with recurrent pneumonia and neuropathy
[12]. It is not known if HTLV-3 or -4 are associated with disease
in humans.
HTLV-1 and -2 infections are transmitted via breastfeeding,
sexual contact, and parenteral transmission via blood transfusion
and intravenous drug use [5,12]. HTLV is estimated to infect 10 to
20 million people worldwide and is endemic in Japan, the
Melanesian islands, the Middle East, sub-Saharan Africa, South
America and the Caribbean [13–16]. In South America and the
Caribbean, specifically in Jamaica, Martinique, Guyana, French
Guyana, Colombia, and the north of Brazil, HTLV-1 infection is
frequent among people of African descent, whereas in Peru and
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northern Argentina it is more prevalent among indigenous people
[17–21].
In Peru, most HTLV infections have been reported in
indigenous people from the Andean Region (Quechua and
Aymara ethnicities), and among African-Peruvian and mestizo
populations (a mix of Spanish and Andean indigenous blood)
[15,20,22,23]. In contrast, there is limited information about
HTLV infection in Amazonian ethnic groups, with limited reports
of HTLV infection in Shipibo-Konibo, Kechwa-Lamas, Wampis,
and Harakmbut villages [19,21,24]. HTLV has also been reported
in populations at high risk for sexually transmitted infections, such
as female sex workers (FSW) and men who have sex with men
(MSM) [25–27].
As part of a previous study conducted among ten indigenous
groups in the Peruvian Amazon, we found 18 HTLV infections
restricted to the Shipibo-Konibo people, one of the largest
Peruvian Amazonian ethnic groups residing along the Ucayali
river [24]. However the sample size for that study limited the
exploration of risk factors for the infection. Therefore, the
objective of our study was to conduct a population-based study
in the Shipibo-Konibo ethnic group to determine the prevalence
and risk factors for HTLV-1 and HTLV-2 infections among
women 15 to 39 years of age.
Methods
Ethics Statement
Our study was approved by the Institutional Review Boards
(IRB) of the University of Washington in Seattle, the Universidad
Peruana Cayetano Heredia, and U.S. Naval Medical Research
Unit No.6 (NAMRU-6) in Callao, Peru. All enrollees provided
written informed consent prior to their participation in our study.
If participants were at least 18 years old, or between 15 and 17
years of age and married/cohabitating for two or more years, and
they agreed to participate, they were invited to participate and
asked to sign the informed consent. Other consenting eligible
women signed an assent and their parent or legal guardian signed
an informed consent. The IRB considered participants between 15
and 17 years of age and married/cohabitating for two or more
years as emancipated, not requiring parental permission for
enrollment. In the context of Amazonian ethnic groups, it is
common for women to become emancipated before 18 years of
age, usually through marriage or cohabitation. At this age they
leave their parent’s home, raise their children and provide
economic support for their families.
Study Design
As part of a study to determine the association between HTLV
and cervical HPV infection, between July and December 2010 we
conducted a comprehensive screening for HTLV infection among
Shipibo-Konibo women 15 to 39 years old who agreed to
participate and lived in any of the Shipibo-Konibo communities
located in Lima or within four hours (most often within one hour)
by car or boat from the city of Pucallpa. The screening was
conducted through household visits. We defined women as
belonging to the Shipibo-Konibo ethnic group if they had at least
one of the following characteristics: 1) they self-identified as
Shipibo-Konibo, 2) they spoke Shipibo-Konibo language, or 3) at
least one of their parents belonged to the Shipibo-Konibo ethnic
group.
Figure 1. Frequency of HTLV-1 and -2 infections per community in the Ucayali region.
doi:10.1371/journal.pone.0073978.g001
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Table 1. Factors associated with human T cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections among women from the
Shipibo-Konibo ethnic group.
Variable HTLV-1 Positive/Tested (%) PR (95% CI) HTLV-2 Positive/Tested (%) PR (95% CI)
Age, years (mean, SD) 28.2 (7.16) 1.06 (1.04–1.08) 28.9 (6.49) 1.08 (1.05–1.10)
Education
More than primary education 42/899 (4.7) 1.0 35/892 (3.9) 1.0
Primary education or less 32/303 (10.6) 2.26 (1.51–3.39) 12/283 (4.2) 1.11 (0.66–1.86)
Has migrated from her community
No 21/400 (5.3) 1.0 8/387 (2.1) 1.0
Yes 53/802 (6.6) 1.26 (0.71–2.22) 39/788 (5.0) 2.73 (1.15–6.46)
Marital status
Single/Separated/Widower 15/385 (3.9) 1.0 12/382 (3.1) 1.0
Married/Cohabitating 59/817 (7.2) 1.85 (1.15–2.98) 35/793 (4.4) 1.37 (0.94–1.99)
Sexually active
No 3/95 (3.2) 1.0 1/93 (1.1) 1.0
Yes 71/1,101 (6.5) 2.04 (0.84–4.96) 46/1,076 (4.3) 3.89 (1.31–11.57)
Age at first sexual intercourse
(mean, SD)
14.8 (1.33) 0.91 (0.81–1.02) 14.8 (1.69) 0.93 (0.79–1.08)
Age at first pregnancy, mean (range) 16.6 (12–25) 0.91 (0.81–1.02) 17.1 (12–22) 0.92 (0.76–1.11)
New sexual partner within the last 12
months
No 65/979 (6.6) 1.0 40/954 (4.2) 1.0
Yes 6/117 (5.1) 0.77 (0.31–1.91) 6/117 (5.1) 1.25 (0.60–2.62)
Have previously worked at a logging
camp
No 70/1,157 (6.1) 1.0 45/1,132 (4.0) 1.0
Yes 4/45 (8.9) 1.47 (0.56–3.89) 2/43 (4.7) 1.20 (0.46–3.12)
Characteristics of the last sex partner
Stable last sex partner 67/1,020 (6.6) 1.0 42/995 (4.2) 1.0
Non-stable last sex partner 4/81 (4.9) 0.75 (0.27–2.13) 4/81 (4.9) 1.17 (0.48–2.84)
Age of most recent sex partner
Current sex partner older 51/898 (5.7) 1.0 32/879 (3.6) 1.0
Current sex partner younger or same age 20/200 (10.0) 1.76 (1.22–2.55) 14/194 (7.2) 2.04 (1.00–3.88)
Lives with current sex partner
No 14/318 (4.4) 1.0 10/314 (3.2) 1.0
Yes 57/780 (7.3) 1.66 (1.03–2.68) 36/759 (4.7) 1.45 (0.86–2.45)
Knows that partner had
another partner
No 15/241 (6.2) 1.0 7/233 (3.0) 1.0
Yes 13/310 (4.2) 0.67 (0.34–1.34) 19/316 (6.0) 2.00 (0.83–4.81)
Didn’t know 43/545 (7.9) 1.27 (0.69–2.34) 20/522 (3.8) 1.21 (0.60–2.47)
Used condom at last sexual
intercourse
No 71/970 (7.3) 1.0 43/942 (4.6) 1.0
Yes 0/126 (0.0) 0.00 (p,0.001)* 3/129 (2.3) 0.52 (0.20–1.34)
Partner belongs to the
Shipibo-Konibo ethnic group
No 13/220 (5.9) 1.0 8/215 (3.7) 1.0
Yes 57/873 (6.5) 1.10 (0.58–2.12) 38/854 (4.5) 1.17 (0.44–3.08)
Most recent sex partner
worked at a logging camp
No 43/800 (5.4) 1.0 33/790 (4.2) 1.0
Yes 26/247 (10.5) 1.96 (1.35–2.85) 11/232 (4.7) 1.04 (0.43–2.48)
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Recruitment Process
Details of the recruitment process and laboratory techniques are
described elsewhere [21]. Briefly, in our study we first established
community advisory boards (CABs) in Lima and Pucallpa. The
objective of these CABs was to provide advice regarding
approaches to engage the communities in the project and to
receive feedback regarding study procedures. After receiving
feedback from the CABs, we initiated visits to the communities.
The study visits were divided into two phases. In the first phase, we
visited the leader of each community selected for the project. If the
leader agreed to participate in the study with his community, he
signed the community informed consent; we then conducted a
census of the community to identify eligible women. Later on, we
individually approached all eligible women at their home to assess
their interest in participation. Participants who were at least 18
years old, or between 15 and 17 years of age and married or
cohabitating for two or more years, and willing to participate, were
asked to sign the informed consent. Women who were 15 to 17
years of age but not married or cohabiting were asked to sign an
assent in addition to a signed informed consent from their parent
Table 1. Cont.
Variable HTLV-1 Positive/Tested (%) PR (95% CI) HTLV-2 Positive/Tested (%) PR (95% CI)
Was breastfeed by a person
other than her mother
No 37/689 (5.4) 1.0 24/676 (3.6) 1.0
Yes 37/513 (7.2) 1.34 (0.88–2.06) 23/499 (4.6) 1.35 (0.86–2.12)
Had ever received blood transfusion
No 73/1186 (6.2) 1.0 46/1,159 (4.0) 1.0
Yes 1/16 (6.3) 1.02 (0.13–7.83) 1/16 (6.3) 1.61 (0.38–6.84)
Had bleeding during a dental
procedure
No 74/1,199 (6.2) 1.0 46/1,171 (3.9) 1.0
Yes 0/3 (0.00) 0.00 (p = 1.00)* 1/4 (25.0) 6.50 (1.12–37.62)
Family history of leukemia
or lymphoma
No 69/1,125 (6.1) 1.0 45/1,101 (4.1) 1.0
Yes 2/30 (6.7) 1.09 (0.23–5.18) 2/30 (6.7) 1.67 (0.61–4.54)
Family history of Tropical Spastic
Paraparesis
No 67/1092 (6.1) 1.0 45/1070 (4.2) 1.0
Yes 2/21 (9.5) 1.55 (0.32–7.62) 0/19 (0.0) 0.00 (p = 1.00)*
Ever had crusted scabies for
more than a month
No 69/1,163 (5.9) 1.0 42/1,136 (3.7) 1.0
Yes 5/36 (13.9) 2.34 (0.60–9.10) 5/36 (13.9) 3.09 (1.10–8.71)
History of TBC
No 69/1,176 (5.9) 1.0 45/1,152 (3.9) 1.0
Yes 5/26 (19.2) 3.28 (1.61–6.66) 2/23 (8.7) 2.27 (0.87–5.97)
*Confidence interval cannot be calculated.
doi:10.1371/journal.pone.0073978.t001
Table 2. Multivariate analysis of factors associated with human T cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections in
women from the Shipibo-Konibo ethnic group.
Model Adjusted Prevalence ratios (95% CI)
Model for HTLV-1 infection
Age 1.04 (1.00–1.08)
Primary education or less 2.01 (1.25–3.24)
Last sex partner younger or same age 1.66 (1.00–2.74)
Last sex partner worked at a logging camp 1.73 (1.09–2.75)
Model for HTLV-2 infection
Age 1.08 (1.03–1.12)
doi:10.1371/journal.pone.0073978.t002
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or legal guardian. Afterwards, we administered a face-to-face
questionnaire in Spanish that included sections on demographics,
previously identified risk factors for HTLV infection (e.g.
prolonged breastfeeding, blood transfusion), risk behaviors for
sexually transmitted infections (STI), information regarding most
recent sexual partner and symptoms of HTLV-associated diseases.
Then we took a venous blood sample to test for HTLV infection
[21].
Sample Collection and Transportation
Venous blood samples were collected using 10 ml vacuum
blood collection tubes, transported in coolers and delivered within
6 hours of collection to the laboratory in Lima or Pucallpa. Serum
was promptly separated, divided into aliquots in vials and frozen at
220uC. Frozen serum aliquots were sent weekly for HTLV testing
from Pucallpa to the NAMRU-6 laboratory in Callao via air
courier in Styrofoam coolers wrapped in metal. Serum samples
obtained in Lima were sent directly to NAMRU-6 for processing
and analysis.
HTLV Testing Techniques
HTLV testing was performed at NAMRU-6 in Callao, Peru. A
woman was considered to be HTLV infected if she had a positive
test for HTLV ELISA (Vironostika, North Carolina), and the
confirmatory Western blot assay (HTLV-1/2 Blot 2.4, Genelabs
Diagnostics, Singapore) revealed bands representing Gag (p24,
p19) and Env proteins (Gp46, GD21 and rgp 46-I). An individual
was considered HTLV-2 seropositive if the ELISA assay was
positive and confirmatory Western blot assay revealed bands
representing p24, GD21 and rgp46-II. If Gag and Env proteins
were absent, but other HTLV specific bands, such as p53 or p19
were present, the individual was considered indeterminate.
Subjects with indeterminate results were excluded from the
analysis. PCR testing was not performed since the specimens
needed for this testing were not collected in the study.
Provision of HTLV Results
Approximately two months after the first visit, we carried out a
second visit to the communities to deliver HTLV test results [21].
HTLV positive participants were informed that HTLV is a
lifelong infection, that it is not the AIDS virus and that it does not
cause AIDS. They were also given information regarding modes of
transmission. HTLV-1 positive participants were given informa-
tion about potential health conditions associated with the virus and
the probability of developing these conditions. HTLV-1 positive
women, and particularly pregnant and breastfeeding women were
given information about the increased risk of HTLV-1 transmis-
sion to their offspring if they breastfeed longer than 6 months.
However, we did not provide a specific recommendation to stop
breastfeeding. HTLV-2 positive participants were given informa-
tion about the limited association with affecting health conditions.
Statistical Methods
Analyses were performed using Stata (v8.0; Stata Corp., College
Station, TX). To identify factors associated with HTLV-1 and
HTLV-2 infections, crude and adjusted prevalence ratios (PR) and
their corresponding 95% confidence intervals were estimated
using generalized linear models adjusting by community of
residence. Analysis of HTLV-1 and 2 infections were conducted
separately because of their potential differences in risk factors.
Variables independently associated with either HTLV infection at
a level of significance of 0.1 were included in a multivariate model
that was refined using backward stepwise selection process.
Predictors significant at the 0.05 level were retained in the final
model.
Results
Between July and December 2010, we approached leaders of 21
Shipibo-Konibo communities and 19 consented participation of
their communities. Two communities were located in Lima, and
17 were Amazon jungle communities located near the city of
Pucallpa. In these communities we approached 1,460 women, of
whom 58 refused to participate. Of the 1,402 consenting women
149 were excluded because they did not belong to the Shipibo-
Konibo ethnic group. All the remaining 1,253 eligible women
could speak Spanish. Of these women, 74 (5.9%) tested positive for
HTLV-1, 47 (3.8%) for HTLV-2 infection, and four (0.3%) had
indeterminate results. Participants with indeterminate results were
excluded from further analysis. The combined HTLV-1/2
prevalence was 9.7%. There were no dual infections. HTLV
infected participants were born in seven out of 10 districts included
in the Ucayali region and in 4 out of 11 districts included in the
Loreto region. The distribution of HTLV within communities did
not follow a clear geographical pattern. Figure 1 shows the
frequency of HTLV-1 and -2 positive individuals per community
in the Ucayali Region. To protect the identity of the communities
participating, only their relative locations are shown and the two
easily identifiable communities in Lima were excluded. This is in
response to the request of the IRB which agreed with the
communities to never report HTLV prevalence by community.
HTLV-1 infected women were more likely than HTLV-
negative participants to be older (There was a 4% increase in
HTLV-1 prevalence for each additional year of age), less
educated, married or cohabiting, to have a last sexual partner
either younger or of the same age than HTLV negative women, to
live with current sex partner, to not use a condom in their last
sexual intercourse, to have a last sex partner who worked at a
logging camp and to self-report a history of tuberculosis (Table 1).
HTLV-2 infected women were more likely to be older and not
living in the community where they were born. They were also
more likely to be sexually active, to have a last sexual partner
younger or of the same age than HTLV negative women, to report
a history of bleeding during a dental procedure and a history of
crusted scabies (Table 1).
We did not find an association between having had a partner
who used intravenous drug use, having tattoos, piercing or surgery
and HTLV-1 or -2 infection (data not shown). We were not able to
evaluate duration of breastfeeding as a risk factor for HTLV-1 or -
2 infection, since 850 (68.1%) of participants did not recall this
information. When analyzing women who knew the duration of
breastfeeding, the mean duration of breastfeeding was similar for
both HTLV seropositive and seronegative participants (15.3
months vs. 15.1 months, p = 0.85).
Overall, 15.0% (17) participants who reported they were
pregnant at the time of the interview were infected with HTLV,
10 with HTLV-1 and 7 with HTLV-2. The mean number of
sexual partners during the last 12 months among HTLV negative,
HTLV-1 and HTLV-2 positive participants was similar (1.0 vs. 1.0
vs. 1.2 partners). Among sexually active participants, the combined
HTLV-1 and -2 prevalence was 10.2%, whereas among partic-
ipants reporting not having initiated sexual activity the prevalence
was 4.2%, suggesting vertical transmission is a common cause of
HTLV-1 and -2 infection.
In the multivariate analysis, factors associated with HTLV-1
infection were age, having primary education or less, having the
most recent sex partner either younger or of the same age, and
HTLV in the Peruvian Amazon
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having the most recent sex partner who worked at a logging camp.
The only factor independently associated with HTLV-2 infection
was age (Table 2).
Discussion
To our knowledge, this is the largest population-based study to
assess the prevalence of HTLV-1 and -2 infections in indigenous
populations in Latin America. We found a combined HTLV-1
and -2 prevalence of 9.7% among Shipibo-Konibo women, the
highest prevalence described in an indigenous group in Peru.
In the multivariate analysis, older age was associated with both
HTLV-1 and -2 infections. Other studies that have assessed risk
factors for HTLV infection have reported that seroprevalence
increases with age, suggesting that sexual intercourse plays an
important role in the transmission of this virus [28,29], or
suggesting a cohort effect for an infection that is diminishing. The
detection of HTLV infection among women reporting not having
initiated sexual activity, suggests that mother-to-child transmission
is also present. The high prevalence found in this study along with
the long duration of breastfeeding reported (mean = 15 months)
could explain high rates of vertical transmission.
We also found that lower education level was associated with
HTLV-1 infection. In a study in Salvador, Brazil, formal
education of less than 7 years was associated with HTLV-1
infection in females [30]. A study in Iran also found a higher
prevalence of HTLV-1 infection observed among illiterate people
compared to participants with higher levels of education [31]. As
many of the traditional practices that may have perpetuated the
persistence of HTLV-1 infection within this ethnic group (shared
breastfeeding, tattoos, polygyny) have decreased with westerniza-
tion and with increasing access to education.
In our study, having a most recent sex partner who was younger
or of the same age, and having a most recent sex partner who
worked at a logging camp were both associated with HTLV-1
infection. While the first finding is intriguing, a previous study that
assessed risk factors for STI among men from 10 indigenous
groups in the Peruvian Amazon found that illegal logging camps
were venues where heterosexual males were often exposed to
unprotected sex with FSW and MSM, and therefore at higher risk
for acquiring HTLV and other STI [32]. Other studies have
reported the prevalence of HTLV-1 infection among women
increased with a younger initiation of sexual activity, higher
number of sex partners, history of an STI and higher number of
different men fathering a child by the woman [33–35]. In our
study, the age of sexual initiation and the number of partners in
the past year were similar for HTLV-1 positive and negative
women but partner characteristics, such as age and previous work
at a logging camp, were different.
HTLV-2 infection was associated with a self-reported history of
crusted scabies and HTLV-1 infection was associated with a
history of tuberculosis. Crusted scabies is a rare but severe
infection caused by massive infestation with Sarcoptes scabiei var.
hominis [36,37]. In a hospital study in Brazil, all patients presenting
with crusted scabies tested positive for HTLV-1 [38]; we have not
identified previous reports of crusted scabies in patients with
HTLV-2 infection. Regarding the association between HTLV-1
and tuberculosis, a case control study in Brazil reported a
statistically significant increase in the risk of tuberculosis in subjects
infected with HTLV-1 [39]. HTLV-1 has also been associated
with worse outcome of tuberculosis and with a mortality rate of
25% among those infected with HTLV-1, compared with 8% in
those without HTLV-1 infection [40].
Although we included non-sexually active women of reproduc-
tive age, one limitation of our study is the exclusion of participants
under 15 years of age that would have provided valuable data
regarding vertical transmission.
In conclusion, HTLV infection is endemic among Shipibo-
Konibo women, particularly among older and less educated
women. Remarkably, two characteristics of the sexual partner
(younger age and labor history) were associated with infection in
women. These results suggest the need for implementation of both
HTLV screening during the antenatal healthcare visits of Shipibo-
Konibo women, as well as counseling about the risk of HTLV
transmission through prolonged breastfeeding in women infected
with the virus. We also suggest the implementation of programs
oriented towards preventing sexual transmission of this virus
through educational interventions that cover safe-sex behavior and
condom use. Additionally, we suggest clinical follow-up of HTLV
infected people in order to provide early diagnosis and treatment
of HTLV-associated diseases. For an intervention to be successful
and tailored to this indigenous community, researchers should
integrate input from the Shipibo-Konibo community into the
development of evidence-based interventions.
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